Join us for in April for BIOMEDevice Executive Forum as we focus on convergence and cross-sector collaborations among biotechnology, medical device, IVD, and pharmaceutical companies. This two-day conference will provide you with the resources you need to strengthen connections between key stakeholders involved in investing, partnering, licensing, and developing business opportunities in the rapidly growing market for innovative healthcare products. The forum's scope moves beyond the FDA's definition of a combination product to address the paradigm shift in the life sciences. Join us to hear what's driving convergence within and across the life science sectors and examine strategies to harness the potential of innovation.
Invest two days at the forum and walk away empowered with critical information to navigate the complex landscape of convergent medical technologies and maintain a competitive advantage.
Hear where convergence is headed from leaders in the life science industry Identify and analyze key areas for growth and strategies to assess risk
- Discuss how medtech entrepreneurs can distinguish themselves in a crowded market
- Identify and examine new models for cross-sector collaborations
- Analyze innovation in the areas of drug delivery and diagnostics
- Study the unique challenges and opportunities posed by convergence—focusing on strategies to address the regulatory, reimbursement, and intellectual property issues
Who Should Attend
Senior-level executives at biotechnology, medical device, and pharmaceutical companies with responsibility for corporate management or business development; R&D executives from mature and emerging life sciences firms; investors in medical technology ventures, including angel investors, venture capitalists, and investment bankers; and industry analysts.
About the Sponsors and Producers
R&D Directions provides insight into pharmaceutical research and development, from discovery through clinical trials and submission. Leaving the hard science to other publications, R&D Directions focuses on pharmaceutical companies' R&D business strategies and decisions. Editorial content covers drugs, therapeutic categories, industry segments, and strategies, and imparts extensive intelligence on products in the pipeline. Although R&D Directions contains a wealth of medical and scientific information, it is written in a non-clinical, non-technical style.
IVD Technology (IVDT) is the only trade journal designed exclusively for manufacturers of in vitro diagnostic products. Written by leading experts in their fields, IVDT's peer-reviewed articles cover a wide range of technical and regulatory topics. The publication’s primary focus is on diagnostics technologies—including research, development, and manufacturing. IVDT articles contain authoritative information on all aspects of manufacturing immunoassays, nucleic-acid-based diagnostics, clinical chemistry tests, and related instrumentation.
The Massachusetts Medical Device Industry Council (MassMEDIC) is the voluntary grassroots association of medical device manufacturers and associated companies in the Commonwealth. MassMEDIC is the only organization in New England dedicated solely to promoting the unique interests of the medical device industry and strives to create a positive environment which will nurture developing companies, retain and help established medical device companies to grow, and attract new companies to Massachusetts.